Profil
Dibang Lin is the founder of Cali Biosciences Co. Ltd.
(founded in 2021) and Shenzhen Hongbangsheng Asset Management Co. Ltd.
(founded in 2014).
He is currently the Chairman & General Manager of Cali Shenzhen Biosciences Co. Ltd., Chairman & General Manager of Liye Pharmaceutical Co. Ltd., Chief Financial Officer & Director of Cali Biosciences Us LLC, Executive Director of Shanghai Qigui Film & Television Culture Co. Ltd., Executive Director of Shanxi Liye Pharmaceutical Co. Ltd., Director of Hunan Liye Real Estate Development Co. Ltd., Director of Liye Jingcheng Real Estate Development Co. Ltd., and Director of Hubei Liye Biological Products Co. Ltd.
His former job was as Manager-Finance Department at ChinaLin Securities Co., Ltd.
from 2013 to 2014.
Postes actifs de Dibang Lin
| Sociétés | Poste | Début |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Fondateur | 17/03/2021 |
| Cali Biosciences Us LLC | Directeur Financier/CFO | - |
| Cali Shenzhen Biosciences Co. Ltd. | Président | - |
| Shanghai Qigui Film & Television Culture Co. Ltd. | Directeur/Membre du Conseil | 01/08/2017 |
| Shanxi Liye Pharmaceutical Co. Ltd. | Directeur/Membre du Conseil | 01/06/2017 |
| Hunan Liye Real Estate Development Co. Ltd. | Directeur/Membre du Conseil | 01/06/2016 |
| Liye Jingcheng Real Estate Development Co. Ltd. | Directeur/Membre du Conseil | 01/05/2016 |
| Hubei Liye Biological Products Co. Ltd. | Directeur/Membre du Conseil | 01/05/2016 |
| Liye Pharmaceutical Co. Ltd. | Président | 01/05/2015 |
Anciens postes connus de Dibang Lin
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHINALIN SECURITIES CO., LTD | Finance |
| Entreprise privées | 10 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Shenzhen Biosciences Co. Ltd. | |
| Cali Biosciences Us LLC | |
| Shanghai Qigui Film & Television Culture Co. Ltd. | |
| Shanxi Liye Pharmaceutical Co. Ltd. | |
| Hunan Liye Real Estate Development Co. Ltd. | |
| Liye Jingcheng Real Estate Development Co. Ltd. | |
| Hubei Liye Biological Products Co. Ltd. | |
| Liye Pharmaceutical Co. Ltd. | |
| Shenzhen Hongbangsheng Asset Management Co. Ltd. |